Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trizivir + Tenofovir in Multiresistant HIV Patients With Virological Failure
NCT00356616Phase 4Terminated
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Sep 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of abacavir and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Variations in the immune status of patients at 48 weeks. Started Sep 2005; status: terminated.
02
Drugs
abacavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00356616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356616.